CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation is a research paper published in Signal Transduction and Targeted Therapy (2024). On theSindex it has a DataRank of 0.489. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.489
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: P30 CA008748
Yasuda Memorial Medical Foundation (Yasuda Medical Foundation)
Grant: NA
National Institutes of Health
Grant: 5R35CA263816-02
Novel therapeutic development for small cell lung cancer
National Institutes of Health
Grant: 5P01CA163227-09
Androgen Receptor Action in Castration Resistant Prostate Cancer
National Institutes of Health
Grant: 5U24CA213274-02
Coordinating center for the NCI small cell lung cancer research consortium
National Institutes of Health
Grant: 5R01CA264078-02
Drivers of histologic transformation in EGFR-mutant lung cancer
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5P50CA097186-13
Clinical Development of Therapeutic Strategies Targeting Damage Responses in the Prostate Tumor Microenvironment
FWCI
4.33
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals